What is the approach to differentiating nephritic versus nephrotic glomerular disease, including urinalysis sediment findings and indications for renal biopsy?

Approach to Glomerular Disease: Nephritic vs. Nephrotic Differentiation

Differentiate nephritic from nephrotic syndrome primarily by the degree of proteinuria and presence of active urinary sediment: nephrotic syndrome presents with heavy proteinuria (>3.0 g/24 hours), hypoalbuminemia (<3.0 g/dL), and edema, while nephritic syndrome features hematuria with dysmorphic RBCs, RBC casts, hypertension, and typically less proteinuria with worse kidney function. 1

Clinical Syndrome Differentiation

Nephrotic Syndrome Features

• Proteinuria >3.0 g/24 hours (the defining feature)
• Hypoalbuminemia <3.0 g/dL
• Peripheral edema (often presenting as "foamy urine" due to heavy proteinuria) 1, 2
• May have hyperlipidemia and thrombotic complications
• Kidney function may be preserved initially
• Bland urinary sediment (minimal cellular elements)

Nephritic Syndrome Features

• Hematuria with dysmorphic erythrocytes (glomerular origin)
• RBC casts (pathognomonic for glomerulonephritis) 3, 4
• Proteinuria present but typically <3.0 g/24 hours
• Hypertension (new-onset or worsening) 5
• Impaired kidney function at presentation
• Carries poorer prognosis than nephrotic syndrome 1

Critical Urinalysis Sediment Findings

The presence of acanthocytes (dysmorphic RBCs) and cellular casts are diagnostic for glomerulonephritis or vasculitis 3. Examine the sediment systematically:

Glomerular Disease Indicators

• Dysmorphic RBCs/acanthocytes: Indicate glomerular bleeding
• RBC casts: Confirm glomerulonephritis (highly specific)
• WBC casts: Suggest active inflammation
• Proteinuria severity guides syndrome classification

Bland Sediment

• Minimal cellular elements despite heavy proteinuria
• Suggests nephrotic syndrome (minimal change disease, membranous nephropathy, FSGS)

Renal Biopsy Indications

Kidney biopsy is the gold standard for diagnostic evaluation and should be performed when the result will modify treatment or provide essential prognostic information 6. However, treatment may proceed without biopsy in specific circumstances.

Proceed with Biopsy When:

• Diagnosis unclear from clinical and serologic evaluation
• Treatment decisions depend on histopathologic classification
• Prognostic information needed to guide management intensity
• At least 8-10 glomeruli required for adequate diagnostic confidence 6

Treatment May Proceed WITHOUT Biopsy in These Specific Conditions:

• PLA2R antibody-positive membranous nephropathy (especially with normal eGFR)
• MPO+ or PR3+ ANCA vasculitis (serologic diagnosis sufficient)
• Anti-GBM disease (with positive anti-GBM antibodies)
• Alport disease (with genetic confirmation)
• Fabry disease (with enzyme/genetic confirmation)
• Familial FSGS with well-characterized mutations
• Systemic lupus erythematosus (when extrarenal manifestations are diagnostic)
• When biopsy is contraindicated by bleeding risk or other factors 6

Common Clinical Pitfalls

Rapidly progressive glomerulonephritis (RPGN) is a nephrological emergency requiring immediate evaluation and treatment to prevent dialysis-dependent kidney failure 3, 5. Do not delay:

• RPGN presents with rapid deterioration of kidney function over days to weeks
• Requires urgent serologic workup (ANCA, anti-GBM, ANA, complement levels)
• Biopsy typically shows crescentic glomerulonephritis (88% of cases) 7
• Treatment must begin emergently, sometimes before biopsy confirmation

Key Diagnostic Errors to Avoid

• Do not assume histology from clinical syndrome alone: One histologic pattern can present with multiple clinical syndromes, and one disease can produce different histologic pictures 7
• Do not dismiss mild proteinuria: Proteinuria >0.5 g/day or any glomerular hematuria warrants further evaluation 5
• Do not overlook secondary causes: Approximately one-third of glomerulonephritis cases are secondary to systemic diseases (vasculitis, lupus, metabolic disorders, hematologic conditions) 5

Diagnostic Algorithm

1. Quantify proteinuria (24-hour urine or protein-to-creatinine ratio)

   • 3.0 g/24h → nephrotic range

   • <3.0 g/24h → consider nephritic if other features present

2. Examine urinary sediment carefully

   • Dysmorphic RBCs + RBC casts → nephritic syndrome
   • Bland sediment + heavy proteinuria → nephrotic syndrome

3. Assess kidney function and blood pressure

   • Acute kidney injury + hypertension → favor nephritic
   • Preserved function → favor nephrotic

4. Obtain targeted serologies

   • ANCA, anti-GBM, ANA, complement (C3, C4), PLA2R antibody
   • Positive serology may obviate biopsy need in specific conditions 6

5. Determine biopsy necessity

   • Required if diagnosis unclear or treatment modification needed
   • May defer if specific serologic diagnosis established (see list above)

Biopsy adequacy requires light microscopy, immunohistology (IgG, IgA, IgM, C3, C4, C1q, kappa/lambda), and electron microscopy for complete evaluation 6.